Cell Therapy Success Starts Here
0.1
Treat more patients by reliably reaching target dose levels
0.2
Unlock significant
cost savings
0.3
Enhance proliferation of CAR-engineered cells
Synecta cell-derived nanoparticles mimic the physiological activation of immune cells. The result is superior cell quality achieved through a simplified workflow that is faster, more robust, and cost-effective.
Clinical Validation
Synecta Activation and Expansion
